These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9399602)

  • 1. New drug interactions with zidovudine.
    Robertson-Dallas S; Read SE; Bendayan R
    Pharmacotherapy; 1997; 17(6):1198-209. PubMed ID: 9399602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Past, present and future of zidovudine, the first antiretroviral drug].
    Martín Fernández J; Rubio García R; Pulido Ortega F
    An Med Interna; 1998 Mar; 15(3):163-70. PubMed ID: 9567426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.
    Hester EK; Peacock JE
    AIDS; 1998 Mar; 12(4):439-40. PubMed ID: 9520175
    [No Abstract]   [Full Text] [Related]  

  • 6. Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
    Tanuma J; Ishizaki A; Gatanaga H; Kikuchi Y; Kimura S; Hiroe M; Oka S
    Clin Infect Dis; 2003 Oct; 37(7):e109-11. PubMed ID: 13130421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
    Kelleher T; Cross A; Dunkle L
    Clin Ther; 1999 Jul; 21(7):1182-92. PubMed ID: 10463516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
    Altinbaş A; Ozkaya G; Büyükaşik Y; Unal S
    Mikrobiyol Bul; 2007 Jul; 41(3):473-6. PubMed ID: 17933262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on drug interactions with zidovudine.
    Piscitelli SC; Polis MA
    AIDS Patient Care STDS; 1998 Sep; 12(9):687-90. PubMed ID: 15468442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency and characteristics of patients treated with zidovudine and absence of progression of HIV infection].
    Soriano V; Heredia A; Mas A; Vallejo A; Garćia-Lerma G; Bravo R; Gómez-Cano M; Villalba N; Moreno V; Laguna F; Valencia E; Martínez P; González-Lahoz J
    An Med Interna; 1997 Jun; 14(6):282-5. PubMed ID: 9410098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
    Curkendall SM; Richardson JT; Emons MF; Fisher AE; Everhard F
    HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
    Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
    Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular nucleoside pharmacokinetics and pharmacology: a potentially important determinant of antiretroviral efficacy.
    Sommadossi JP
    AIDS; 1998; 12 Suppl 3():S1-8. PubMed ID: 15168717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.
    Ross L; Henry K; Paar D; Salvato P; Shaefer M; Fisher R; Liao Q; St Clair M
    J Hum Virol; 2001; 4(4):217-22. PubMed ID: 11694850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.